COGT
Cogent Biosciences Inc
NASDAQ: COGT · HEALTHCARE · BIOTECHNOLOGY
$35.87
-1.29% today
Updated 2026-04-29
Market cap
$6.29B
P/E ratio
—
P/S ratio
861.15x
EPS (TTM)
$-2.16
Dividend yield
—
52W range
$5 – $44
Volume
2.1M
Cogent Biosciences Inc (COGT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.99M | $6.36M | $8.36M | $9.73M | $22.50M | $7.87M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +112.8% | +31.5% | +16.4% | +131.1% | -65.0% | -100.0% | — | — | — | — |
| Cost of revenue | — | — | — | — | $43709.00 | $25.74M | $147000.00 | $5.88M | $3.59M | $4.40M | $4.62M |
| Gross profit | $2.99M | $6.36M | $8.36M | $9.73M | $22.50M | $-17.87M | $-147000.00 | $-5.88M | $-3.59M | $-4.40M | $-4.62M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -227.0% | — | — | — | — | — |
| R&D | $6.85M | $21.99M | $29.83M | $38.28M | $43.71M | $72.65M | $55.91M | $121.63M | $173.75M | $232.66M | $269.78M |
| SG&A | $2.73M | $3.43M | $4.68M | $7.45M | $10.97M | $17.42M | $19.64M | $26.21M | $34.38M | $43.28M | $63.58M |
| Operating income | $-6.59M | $-19.07M | $-26.15M | $-36.01M | $-32.18M | $-82.20M | $-75.55M | $-147.84M | $-208.13M | $-275.94M | $-333.36M |
| Operating margin | -220.8% | -300.1% | -312.8% | -369.9% | -143.0% | -1044.3% | — | — | — | — | — |
| EBITDA | $-6.41M | $-18.24M | $-24.98M | $-34.68M | $-30.89M | $-34.57M | $-73.56M | $-141.96M | $-204.54M | $-271.59M | $-328.74M |
| EBITDA margin | -214.8% | -287.0% | -298.8% | -356.3% | -137.3% | -439.2% | — | — | — | — | — |
| EBIT | $-6.59M | $-19.07M | $-26.15M | $-36.01M | $-32.18M | $-35.29M | $-75.55M | $-147.84M | $-208.13M | $-275.94M | $-333.36M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $144000.00 | $3.13M | $3.99M | $0.00 | $0.00 | $3.06M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.59M | $-18.12M | $-25.49M | $-34.53M | $-30.27M | $-74.81M | $-72.27M | $-132.64M | $-192.41M | $-255.86M | $-328.94M |
| Net income growth (YoY) | — | -174.9% | -40.7% | -35.5% | +12.3% | -147.1% | +3.4% | -83.5% | -45.1% | -33.0% | -28.6% |
| Profit margin | -220.8% | -285.2% | -304.9% | -354.8% | -134.6% | -950.4% | — | — | — | — | — |